Systems and methods for the treatment of pain through neural fiber stimulation

• US 10,076,663 B2
• Filed: 07/21/2014
• Issued: 09/18/2018
• Est. Priority Date: 11/11/2010
• Status: Active Grant

• Current Assignee: SPR Therapeutics, Inc.
• Original Assignee: SPR Therapeutics, Inc.
• Inventors: Bennett, Maria E., Boggs, II, Joseph W., Grill, Warren M., Chae, John
• Primary Examiner(s): Carey, Michael
• Application Number:
  US14/336,688
• Publication Number:
  US 20140330356A1
• Time in Patent Office: 1,520 Days
• Field of Search: 607 46, 607 48, 607115
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/36057 adapted for stimulating afferent nerves
• CPC Class Codes: A61N 1/36071 Pain

Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

Claims

1. A method of reducing a perception of pain, the method comprising the steps of:

inserting a single contact electrode in-vivo a therapeutically effective distance from a target afferent nerve fiber;

electrically stimulating through the electrode the target afferent nerve fiber to generate an action potential in the target afferent nerve fiber while avoiding generation of unwanted responses in non-target nerve fiber.

2. The method of claim 1, wherein the target afferent nerve fiber comprises a Type Ia or Type Ib afferent nerve fiber.

3. The method of claim 1, wherein the generation of unwanted responses in the non-target nerve comprises generation of action potentials in a small sensory nerve fiber.

4. The method of claim 1, wherein the generation of unwanted responses in the non-target nerve fiber comprises generation of action potentials in Type III and Type IV afferent nerve fibers.

5. The method of claim 1, wherein the generation of unwanted responses in the non-target nerve fiber comprises generation of action potential in a motor sensory nerve fiber.

6. The method of claim 1, wherein the target afferent nerve fiber comprises Type Ia and Type Ib afferent nerve fibers.

7. The method of claim 1, further comprising percutaneously inserting a lead, the lead operatively coupled with the electrode.

8. The method of claim 1, wherein the target afferent nerve fiber is located within a region of pain.

9. The method of claim 1, wherein the target afferent nerve fiber is located outside of a region of pain.

10. A method of reducing a perception of pain, the method comprising the steps of:

percutaneously inserting a lead, the lead having a single contact electrode, wherein the electrode is at a therapeutically effective distance from a target afferent nerve fiber;

electrically stimulating through the electrode the target afferent nerve fiber to generate an action potential in the target afferent nerve fiber while avoiding generation of unwanted responses in non-target nerve fiber.

11. The method of claim 10, wherein the target afferent nerve fiber includes a Type I or Type Ib afferent nerve fiber.

12. The method of claim 11, wherein the non-target nerve fiber includes Type III and Type IV afferent nerve fibers.

13. The method of claim 12, wherein the electrical stimulation relieves pain.

14. The method of claim 13, further comprising:

removing the lead and electrode, wherein pain relief is generally maintained for a time.

15. The method of claim 14, wherein the time is two to three weeks.

16. The method of claim 11, wherein the non-target nerve fiber includes an efferent nerve fiber.

17. The method of claim 10, wherein the target afferent nerve fiber includes at least one large sensory nerve fiber.

18. The method of claim 14, wherein the non-target nerve fiber includes at least one small sensory nerve fiber.

19. The method of claim 18, wherein the electrical stimulation relieves pain.

20. The method of claim 19, further comprising:

removing the lead and electrode, wherein pain relief is generally maintained for a time.

21. The method of claim 20, wherein the time is two to three weeks.

22. The method of claim 14, wherein the non-target nerve fiber includes a motor sensory nerve fiber.

23. A method of reducing a perception of pain, the method comprising:

electrically stimulating through a single contact electrode inserted in-vivo a plurality of target afferent sensory nerve fibers to generate an action potential in the plurality of target afferent sensory nerve fibers while avoiding generation of action potentials in small sensory nerve fibers and motor nerve fibers.

24. The method of claim 23, wherein the target afferent sensory nerve fibers are at least one of Type Ia and Ib afferent nerve fibers.

25. The method of claim 24, wherein the small sensory nerve fibers include Type III and IV afferent nerve fibers.

26. The method of claim 25, wherein the motor nerve fibers include efferent nerve fibers.

27. The method of claim 23, further comprising percutaneously inserting a lead, wherein the electrode extends from the lead.

28. The method of claim 27, wherein the electrode is inserted a therapeutically effective distance from the target sensory nerve fibers.

29. The method of claim 28, wherein the therapeutically effective distance is 1 mm from the target sensory nerve fiber.

30. The method of claim 23, wherein the electrical stimulation is applied for a treatment time to relieve pain.

31. The method of claim 30, wherein after the treatment time pain relief is maintained for a period of time, such period of time at least 17 times the treatment time.